Åsa Johansson

Uppsala University

Scientific Lead for Precision Medicine at SciLifeLab

Key Publications
Oral contraceptive use increases bone density and lower the risk of osteoporosis
2025
Precision Omics Initiative Sweden (PROMISE) will integrate research with healthcare
Nature Medicine, 2025
Genomic and proteomic signatures highlight diverse pathways between obesity and type-2 diabetes
2025
Contemporary menopausal hormone therapy and risk of cardiovascular disease: Swedish nationwide register based emulated target trial.
BMJ (Clinical research ed.), 2024
Effects of oral contraceptives and menopausal hormone therapy on the risk of rheumatoid arthritis: a prospective cohort study
Rheumatology, 2024

Research Interests

Every fourth individual in Europe has ever been diagnosed with a common disease, such as cancer, asthma, diabetes, or myocardial infarction. The aim of our research is to determine genetic and lifestyle factors that influence human phenotypes, clinical variables, and risk of disease. We also evaluate how such factors can be used to predict, or even prevent, common diseases. The goal is to broaden our knowledge of disease pathophysiology, which is important for developing drugs to prevent, delay progression, or relieve symptoms of disease.

Group Members

Azimi, Tayebe
Deng, Yaqi
Ek, Weronica
Hadizadeh, Fatemeh
Johansson, Therese
Karlsson, Torgny
Koteci, Ardita
Lo Faro, Valeria
Mutie, Pascal
Rask-Andersen, Mathias
Schmitz, Daniel

Last updated: 2023-12-20

Content Responsible: David Gotthold(david.gotthold@scilifelab.se)

Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.
Help Us Improve!
We want to better match our services with your needs—take our short survey and help shape SciLifeLab’s digital future. You can also join our user panel for occasional feedback opportunities and early access to new tools.